ADD-ON MULTIPLE SUBMUCOSAL INJECTIONS OF RNA OLIGONUCLEOTIDE GUT-1 TO TUMOR NECROSIS FACTOR-ANTAGONIST TREATMENT IN PATIENTS WITH MODERATE-TO-SEVERE ULCERATIVE COLITIS: AN INVESTIGATOR-INITIATED TRIAL

Kenji Suzuki  1     Yukinori Sameshima  2     Junji Yokoyama  2     Shuji Terai  2     Hiroyuki Yoneyama  3     Raja Atreya  4     Markus F. Neurath  5     Toshifumi Hibi  6     Hitoshi Asakura  6    
1 Niigata University Medical and Dental Hospital, Niigata, Japan
2 Sameshima Hospital, Kagoshima, Japan
3 GUT Inc., Kochi, Japan
4 University Erlangen-Nuremberg, Erlangen, Germany
5 University of Erlangen-Nuremberg, Erlangen, Germany
6 Kitasato University, Tokyo, Japan

Topic
IBD

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing